Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Research Frontiers (REFR) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Research Frontiers (REFR) over the last 10 years, with Q3 2025 value amounting to $2.8 million.

  • Research Frontiers' Liabilities and Shareholders Equity fell 765.93% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year decrease of 1.98%. This contributed to the annual value of $4.0 million for FY2024, which is 491.16% up from last year.
  • Per Research Frontiers' latest filing, its Liabilities and Shareholders Equity stood at $2.8 million for Q3 2025, which was down 765.93% from $3.2 million recorded in Q2 2025.
  • Research Frontiers' Liabilities and Shareholders Equity's 5-year high stood at $6.0 million during Q3 2022, with a 5-year trough of $2.8 million in Q3 2025.
  • Its 5-year average for Liabilities and Shareholders Equity is $4.2 million, with a median of $4.0 million in 2024.
  • In the last 5 years, Research Frontiers' Liabilities and Shareholders Equity tumbled by 4076.39% in 2022 and then surged by 5543.49% in 2023.
  • Over the past 5 years, Research Frontiers' Liabilities and Shareholders Equity (Quarter) stood at $4.5 million in 2021, then rose by 18.05% to $5.4 million in 2022, then decreased by 28.25% to $3.9 million in 2023, then increased by 4.91% to $4.0 million in 2024, then tumbled by 31.45% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $3.2 million for Q2 2025, and $3.8 million during Q1 2025.